Mana Capital Acquisition (MAAQ) Competitors $0.40 -0.03 (-6.57%) As of 05/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock MAAQ vs. GLYC, EDSA, LPTX, UBX, ABP, EQ, BIVI, PRPH, ABVC, and INABShould you be buying Mana Capital Acquisition stock or one of its competitors? The main competitors of Mana Capital Acquisition include GlycoMimetics (GLYC), Edesa Biotech (EDSA), Leap Therapeutics (LPTX), Unity Biotechnology (UBX), Abpro (ABP), Equillium (EQ), BioVie (BIVI), ProPhase Labs (PRPH), ABVC BioPharma (ABVC), and IN8bio (INAB). These companies are all part of the "pharmaceutical products" industry. Mana Capital Acquisition vs. GlycoMimetics Edesa Biotech Leap Therapeutics Unity Biotechnology Abpro Equillium BioVie ProPhase Labs ABVC BioPharma IN8bio Mana Capital Acquisition (NASDAQ:MAAQ) and GlycoMimetics (NASDAQ:GLYC) are both small-cap manufacturing companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership and valuation. Does the media favor MAAQ or GLYC? In the previous week, GlycoMimetics had 4 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 4 mentions for GlycoMimetics and 0 mentions for Mana Capital Acquisition. GlycoMimetics' average media sentiment score of 0.57 beat Mana Capital Acquisition's score of 0.00 indicating that GlycoMimetics is being referred to more favorably in the news media. Company Overall Sentiment Mana Capital Acquisition Neutral GlycoMimetics Positive Do analysts recommend MAAQ or GLYC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mana Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00GlycoMimetics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is MAAQ or GLYC more profitable? Mana Capital Acquisition's return on equity of 0.00% beat GlycoMimetics' return on equity.Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A GlycoMimetics N/A -230.74%-177.39% Does the MarketBeat Community favor MAAQ or GLYC? GlycoMimetics received 316 more outperform votes than Mana Capital Acquisition when rated by MarketBeat users. However, 100.00% of users gave Mana Capital Acquisition an outperform vote while only 57.74% of users gave GlycoMimetics an outperform vote. CompanyUnderperformOutperformMana Capital AcquisitionOutperform Votes1100.00% Underperform VotesNo VotesGlycoMimeticsOutperform Votes31757.74% Underperform Votes23242.26% Which has stronger earnings & valuation, MAAQ or GLYC? Mana Capital Acquisition has higher earnings, but lower revenue than GlycoMimetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AGlycoMimetics$10K1,638.66-$37.88M-$0.59-0.43 Do institutionals & insiders have more ownership in MAAQ or GLYC? 68.4% of Mana Capital Acquisition shares are owned by institutional investors. Comparatively, 75.2% of GlycoMimetics shares are owned by institutional investors. 8.7% of GlycoMimetics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryGlycoMimetics beats Mana Capital Acquisition on 8 of the 11 factors compared between the two stocks. Get Mana Capital Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for MAAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAAQ vs. The Competition Export to ExcelMetricMana Capital AcquisitionIn Vitro, In Vivo Diagnostic Substances IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$3.23M$3.45M$2.02B$7.93BDividend YieldN/AN/A2.70%4.23%P/E RatioN/AN/A22.5118.55Price / SalesN/AN/A59.38103.29Price / CashN/AN/A51.7234.62Price / BookN/AN/A2.004.25Net IncomeN/AN/A-$333.48M$248.18M7 Day Performance-23.66%-18.29%0.54%0.91%1 Month Performance10.25%18.00%-0.92%2.59%1 Year Performance-43.14%-39.14%7.78%4.02% Mana Capital Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAAQMana Capital AcquisitionN/A$0.40-6.6%N/A-39.1%$3.23MN/A0.001High Trading VolumeGLYCGlycoMimetics2.1178 of 5 stars$0.26+4.1%N/A-83.8%$16.84M$10,000.00-0.4450Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageGap DownEDSAEdesa Biotech3.1316 of 5 stars$2.36+0.4%$21.00+789.8%-47.4%$16.50MN/A-1.2620Upcoming EarningsShort Interest ↓Gap UpLPTXLeap Therapeutics2.4801 of 5 stars$0.40+1.7%$4.92+1,129.5%-87.3%$16.50MN/A-0.2140UBXUnity Biotechnology4.1452 of 5 stars$0.98-0.7%$5.33+445.9%-29.5%$16.48M$240,000.00-0.7560News CoverageABPAbproN/A$0.32-3.9%$4.00+1,157.9%N/A$16.48M$183,000.000.0015Gap UpHigh Trading VolumeEQEquillium2.8306 of 5 stars$0.44-6.7%$3.00+584.5%-71.9%$15.66M$41.10M-3.1340Upcoming EarningsShort Interest ↓BIVIBioVie2.8335 of 5 stars$0.84-6.1%$3.00+257.1%+74.8%$15.50MN/A-0.0910Short Interest ↓Gap UpPRPHProPhase Labs1.037 of 5 stars$0.37+10.1%N/A-93.8%$15.45M$6.77M-0.29130Upcoming EarningsPositive NewsGap UpABVCABVC BioPharma0.7281 of 5 stars$0.98+7.2%N/A-8.8%$15.41M$509,589.00-1.1430Earnings ReportINABIN8bio3.6304 of 5 stars$0.19+2.3%$6.00+3,069.6%-83.7%$15.38MN/A-0.2520Upcoming Earnings Related Companies and Tools Related Companies GLYC Alternatives EDSA Alternatives LPTX Alternatives UBX Alternatives ABP Alternatives EQ Alternatives BIVI Alternatives PRPH Alternatives ABVC Alternatives INAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MAAQ) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mana Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mana Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAAQ Stock Free MAAQ Stock Alerts